MR-guided radiotherapy
HCA Healthcare UK invests £15million to introduce advanced MR-guided radiotherapy with Elekta Unity MR Linac
Dr John Conibear
Consultant Oncologist, HCA Healthcare UK
Dr John Conibear is a Consultant Clinical Oncologist at HCA Healthcare UK and a senior clinical leader at Barts Cancer Centre. He specialises in the non surgical treatment of lung and breast cancers and is an expert in advanced radiotherapy techniques, including MR guided radiotherapy, stereotactic ablative radiotherapy, CyberKnife and Gamma Knife technologies.
Dr Conibear has played a key role in implementing cutting edge radiotherapy services across both NHS and independent healthcare settings.
In his session, John will be exploring how precision radiotherapy is reshaping cancer care, patient experience and the economics of oncology.
Radiotherapy: The technology revolution
Key takeaways
- Radiotherapy remains a core pillar of cancer care and demand continues to rise. Innovation has made treatment more precise, often faster and sometimes much shorter.
- Integration with systemic therapy is crucial because many patients need both.
- The patient value is not just tumour control, but toxicity, experience, recovery and return to normal life. HCA UK’s combination of platforms, people and pathway design positions it strongly for next-generation cancer care.